Good morning to the US, Fanmail (time wise, I am 6h ahead

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel FanMail #34700
577
Good morning to the US, Fanmail (time wise, I am 6h ahead of EST here in Germany, so for me it is already mid afternoon).

To your message:

honestly, my belief is that the CompleteVaccine in fact is "too good" for BigPharma to jump on it. As it is clear as morning air for me, that BigPharma is not interested in the health of their general customer. It is much better to have chronically sick customers, because to such folks they are able to regularly sell their products.
Same way for the mRNA vaccine. Here in Germany our government is currently talking about another Booster shot every 3 to 4 months just to make sure that we are all "well prepared" for the next variant. Same way they are talking about making it mandatory to get vaccinated and serious problems will happen to those, who are still not vaccinated (such as I am). They threaten us with fines, and are even talking about that only the "vaccinated" or "recovered" (the so called 2G rule, as both German words start with a "G" persons are still allowed to go to work (in some potential future that will hopefully never become reality). And even in regards to the "recovered" status, they have recently reduced it from 6 to 3 months. So after a Omicron infection one can only remain without a vaccination for 3 months now, before you would no longer get the benefits of the "2G" status. Why have they changed it to 3 months? Because rumors have it, that a lot of the "unvaccinated" think about having "Corona parties" where they on purpose get themselves infected (believing that an Omicron infection is not as serious as e.g. Delta), to avoid the vaccination.

In this kind of scenario a CompleteVaccine that is claimed to provide immunity for a longer period of time, would not be of interest to such BigPharma companies, as they would only be able to sell dosages of such a vaccine once a year, or maybe even every second, while they can make billions every 3 months with an mRNA vaccine. Why would they get involved with GNBT/NGIO, who may have a superior vaccine? Nobody can make them reliable for the mass occurring serious side effects, and thus it is a license to print money for them, for as long as the CompleteVaccine would not be available.

I know, I know, this does not just sound DISGUSTING, this in fact IS outrageously DISGUSTING, but I am sure that BigPharma companies regularly think that way. Whatever is best for the taxpayers, who are paying the billion dollar bills they hand out to all country governments, does not matter in their eyes, most important is, what is good for them and their shareholders.

The longer I am thinking about this, the more I am convinced that this is what is really going on here. And in conclusion, the reason why GNBT/NGIO likely does not even have a fighting chance (at least in the western world, where these "deep state" players are ruling everything) to be successful with their vaccine development. And in the end it is not Joe Moscato's fault. Heck even the best CEO in the world (who happens to not be involved in the "deep state" games) would not be able to get this working, as it is a steep uphill battle against a very tough/almost impossible to beat opponent.

Regarding your other points about Oral-lyn etc. It all takes money to get these businesses jump started. In the case of Oral-lyn it requires a serious investment in yet another phase III clinical trial. And Joe was not getting tired of always pointing out that he wanted to uplist GNBT to Nasdaq first, before he'd go ahead and raise the required capital to be able to fund this.
In regards to Excellegen, during the May CC it actually sounded as if they were close to getting the required line of credit to get their business jump started. We just don't know what is really going on, as they remained silent ever since, for whatever reason that was.

Regarding your last paragraph, we definitely have a significantly different take on the current situation. I don't think that Joe and the management team really do not care about their subsidiaries or us shareholders. From what I have learned about Joe in the last couple of years is that he may not always make the smartest moves/business decisions, or has the best mannered ways to communicate with us on here, but he definitely thinks that GNBT is "his baby" and will give everything he has to fight for and protect it. And since he has always been very communicative, and I can still recall that one CC where there was a technical issue, and it seem as if nobody was interested in asking questions during the Q&A part of that call. He sounded almost insulted or at least disappointed that nobody seemed to be wanting to ask questions. With that in mind, I absolutely cannot imagine that he remains silent for such a long period of time VOLUNTARILY or because he just couldn't care less. There is no doubt in my mind that there are other reasons why we haven't heard from the company for more than the entire second half of 2021. And that reason might as well be related to first part of my message, meaning this is just yet another part of the measures "deep state" takes to hinder them from being successful with their vaccine development.

This is how I see the current situation.
2

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 245

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 187

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 92

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 120

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 150

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 281

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 148

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading

Top 5 Most Recently Viewed Articles

Proterra Secures $680M in Fund 3, Exceeds Expectations

Updated Category News Views 224

Proterra's Bold Move Shakes the Market Alright, folks. You've got Proterra Investment Partners stepping up and showing its mettle with the close of its third private credit fund. Guess what? They pulled in $680 million, cruising past their $500 million target like a hot knife through butter. That's no small potatoes in the finance world, especially when you add up the...

Continue Reading
Medical Properties Trust Concludes Lawsuit with Viceroy Research

Updated Category News Views 272

Medical Properties Trust Resolves Legal Dispute Medical Properties Trust, Inc. (NYSE: MPW) has successfully settled its lawsuit with Viceroy Research LLC, effectively putting to rest a defamation case that had lingered since the spring of 2023. As a prominent real estate investment trust specializing in healthcare facilities, this resolution enables the company to sharpen...

Continue Reading
Blue Hat Interactive Raises $3.9 Million to Enhance Growth

Updated Category News Views 140

Blue Hat Interactive's Recent $3.9 Million Offering Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a dynamic player in the augmented reality (AR) interactive entertainment sector, announced a substantial registered direct offering of its ordinary shares aimed at raising approximately $3.9 million. The current market capitalization of the company stands at...

Continue Reading
Cybersecurity Market Projected to Surpass $500 Billion by 2030

Updated Category News Views 377

Cybersecurity Market Set for Remarkable Growth The global cybersecurity market is experiencing a significant transformation, expected to reach a staggering $500.70 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2030. This projection illustrates the rising demand for robust cybersecurity solutions, especially in light of escalating...

Continue Reading
Transforming Crypto Mining: ALL4 Mining's Game-Changing App Launch

Updated Category News Views 163

Revolutionizing the World of Crypto Mining ALL4 Mining has taken a bold step into the future by introducing a free mobile app dedicated to cloud mining. This innovative platform not only enhances user experience but also expands the opportunities for both novice and experienced cryptocurrency investors, making it easier and more efficient to mine digital currencies. A New...

Continue Reading